Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

Gambaa Aug. 28 at 9:12 PM

$LQDA Looking forward to handing my lqda shares down to my kids so they can get this ruling any day

1 · Reply

Omnitrader69 Aug. 28 at 6:31 PM

$LQDA Time running out on that Sept 1 idea, come on Judge. We really gonna have to wait even longer?

0 · Reply

HumphreyB Aug. 28 at 4:43 PM

$LQDA Check out two-faced @stevemano $MNKD

1 · Reply

Hamboning2026 Aug. 28 at 2:05 PM

$LQDA As I’ve said before, there will be consecutive down days all the way to $48. Then once that’s reached, $15 should follow sooner than later. Once it drops under $20 I will start offloading my puts.

0 · Reply

KeelinTime Aug. 27 at 8:40 PM

$LQDA

0 · Reply

Hamboning2026 Aug. 27 at 8:25 PM

$LQDA Will consider picking up shares at around $15 which is expected to reach by end of next month based on the chart. Consecutive down days from here should further reinforce my thesis.

2 · Reply

nnnuuu Aug. 27 at 8:03 PM

$LQDA still waiting for a good re-entry

1 · Reply

judgeyoung2 Aug. 27 at 4:39 PM

$LQDA even the stock itself decided it’s not gonna move until this geezer does

0 · Reply

KeelinTime Aug. 27 at 11:20 AM

$LQDA

0 · Reply

grampslol Aug. 27 at 6:33 AM

$MNKD home to afrezza dpi inhaled prandial insulin approved in 2014 ... the only insulin with the FDA black box warning label ... scripts week ending 8/14/26 new 333 refills 528 $QQQ $SPY $LLY $LQDA

0 · Reply

Liquidia reports Q2 EPS 74c, consensus 84c

2026-08-17T09:07:18.000Z - 12 days ago

Liquidia downgraded to Market Perform from Outperform at LifeSci Capital

2026-08-17T08:22:43.000Z - 12 days ago

Liquidia price target raised to $108 from $62 at Wells Fargo

2026-08-17T08:19:39.000Z - 12 days ago

Liquidia price target raised to $92 from $79 at BofA

2026-08-17T07:44:52.000Z - 12 days ago

Liquidia price target raised to $106 from $68 at Raymond James

Aug 12, 2026, 8:30 AM EDT - 17 days ago

Liquidia Earnings Call Transcript: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 17 days ago

Liquidia Earnings release: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 17 days ago

Liquidia Quarterly report: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 17 days ago

Liquidia Slides: Q2 2026

Aug 12, 2026, 6:30 AM EDT - 17 days ago

Liquidia Corporation Reports Second Quarter 2026 Financial Results

Jul 29, 2026, 8:30 AM EDT - 4 weeks ago

Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

2026-07-23T16:00:17.000Z - 5 weeks ago

Liquidia price target raised to $130 from $75 at H.C. Wainwright

UTHR

2026-06-29T10:30:39.000Z - 2 months ago

Liquidia downgraded to Neutral from Buy at BofA

2026-06-22T11:32:52.000Z - 2 months ago

Liquidia price target raised to $109 from $59 at BTIG

Jun 16, 2026, 4:30 PM EDT - 2 months ago

Liquidia Transcript: AGM 2026

Jun 11, 2026, 8:30 AM EDT - 2 months ago

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

2026-06-08T13:08:28.000Z - 2 months ago

Liquidia announces inclusion in S&P SmallCap 600 Index

Jun 8, 2026, 8:30 AM EDT - 2 months ago

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

2026-06-05T10:55:08.000Z - 3 months ago

Liquidia price target raised to $75 from $67 at H.C. Wainwright

2026-06-04T19:30:40.000Z - 3 months ago

Raymond James sees positive readthrough for Liquidia from Hikma v. Amarin

2026-06-04T16:09:07.000Z - 3 months ago

Liquidia rises 17.6%

Jun 3, 2026, 12:45 PM EDT - 3 months ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 8:30 AM EDT - 3 months ago

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

May 19, 2026, 9:30 AM EDT - 3 months ago

Liquidia Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 11:40 AM EDT - 3 months ago

Liquidia Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T18:47:33.000Z - 3 months ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T11:38:21.000Z - 3 months ago

Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-11T21:57:52.000Z - 3 months ago

Liquidia price target raised to $60 from $57 at Jefferies

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Slides: Q1 2026

2026-05-11T11:28:55.000Z - 3 months ago

Liquidia reports Q1 EPS 52c, consensus 41c

May 11, 2026, 6:30 AM EDT - 3 months ago

Liquidia Corporation Reports First Quarter 2026 Financial Results

May 6, 2026, 8:30 AM EDT - 4 months ago

Liquidia Corporation to Participate in Upcoming Investor Conferences

May 4, 2026, 8:30 AM EDT - 4 months ago

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Liquidia Proxy statement: Proxy filing

Apr 15, 2026, 12:45 PM EDT - 4 months ago

Liquidia Transcript: 25th Annual Needham Virtual Healthcare Conference

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Slides: Q4 2025

Mar 5, 2026, 6:30 AM EST - 6 months ago

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 6 months ago

Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026

Jan 14, 2026, 8:15 PM EST - 8 months ago

Liquidia Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 8 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 8:00 AM EST - 10 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 10 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 10 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Slides: FY 2025

Oct 27, 2025, 8:30 AM EDT - 10 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 11 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Sep 3, 2025, 3:45 PM EDT - 1 year ago

Liquidia Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Q2 2025

Aug 12, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 23, 2025, 4:34 PM EDT - 1 year ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 4, 2025, 11:05 AM EDT - 1 year ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 6:30 AM EDT - 1 year ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update

May 23, 2025, 2:28 PM EDT - 1 year ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 13, 2025, 4:40 PM EDT - 1 year ago

Liquidia Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 6:00 AM EDT - 1 year ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025

May 8, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 2, 2025, 5:28 PM EDT - 1 year ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 9, 2025, 8:45 AM EDT - 1 year ago

Liquidia Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 1 year ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 1 year ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 2 years ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 2 years ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Sep 30, 2024, 8:00 AM EDT - 2 years ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 19, 2024, 1:30 PM EDT - 2 years ago

Liquidia Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 16, 2024, 9:41 AM EDT - 2 years ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Gambaa Aug. 28 at 9:12 PM

$LQDA Looking forward to handing my lqda shares down to my kids so they can get this ruling any day

1 · Reply

Omnitrader69 Aug. 28 at 6:31 PM

$LQDA Time running out on that Sept 1 idea, come on Judge. We really gonna have to wait even longer?

0 · Reply

HumphreyB Aug. 28 at 4:43 PM

$LQDA Check out two-faced @stevemano $MNKD

1 · Reply

Hamboning2026 Aug. 28 at 2:05 PM

0 · Reply

KeelinTime Aug. 27 at 8:40 PM

$LQDA

0 · Reply

Hamboning2026 Aug. 27 at 8:25 PM

$LQDA Will consider picking up shares at around $15 which is expected to reach by end of next month based on the chart. Consecutive down days from here should further reinforce my thesis.

2 · Reply

nnnuuu Aug. 27 at 8:03 PM

$LQDA still waiting for a good re-entry

1 · Reply

judgeyoung2 Aug. 27 at 4:39 PM

$LQDA even the stock itself decided it’s not gonna move until this geezer does

0 · Reply

KeelinTime Aug. 27 at 11:20 AM

$LQDA

0 · Reply

grampslol Aug. 27 at 6:33 AM

$MNKD home to afrezza dpi inhaled prandial insulin approved in 2014 ... the only insulin with the FDA black box warning label ... scripts week ending 8/14/26 new 333 refills 528 $QQQ $SPY $LLY $LQDA

0 · Reply

SteelerJon Aug. 26 at 11:08 PM

$LQDA come on!!!😎🏦🏦

0 · Reply

judgeyoung2 Aug. 26 at 2:18 PM

$LQDA what’s wrong with you old ahh geezer

0 · Reply

KeelinTime Aug. 26 at 11:33 AM

$LQDA

0 · Reply

judgeyoung2 Aug. 25 at 8:57 PM

$LQDA Judge Andrewsss??? Hellooo?

0 · Reply

KeelinTime Aug. 25 at 12:25 PM

$LQDA

0 · Reply

SteelerJon Aug. 25 at 1:40 AM

$LQDA 👊🏻🏦🏦

1 · Reply

QuantInsider Aug. 24 at 10:17 PM

$LQDA seeing some action today Noticed those 3,500 Sept 4 $95 call sweeps hitting the ask on InsiderFinance They’re way out there, 35-36% OTM and it feels like a lotto play with just $186K premium Not exactly screaming big money confidence LQDA's down about 6% over the last five days even with today’s +2.4% bounce Those 8/28 $60 put sweeps from 8/21 with $135K premium show some downside caution is still hanging around Earnings were solid on Aug 12 but that insider selling around Aug 19 isn't helping the bullish case Feels more like a wait and see situation

0 · Reply

KeelinTime Aug. 24 at 8:09 PM

$LQDA

0 · Reply

Hamboning2026 Aug. 24 at 3:07 PM

$LQDA Expecting further consecutive down days here all the way to $48. Then will likely touch $12-$15 in the very near term

1 · Reply

Hamboning2026 Aug. 24 at 3:06 PM

$LQDA

1 · Reply

Gambaa Aug. 24 at 2:15 PM

$LQDA What is this green nonsense lets go lower!

0 · Reply

KeelinTime Aug. 24 at 11:10 AM

$LQDA

0 · Reply

Market Cap	6.26B
Revenue (ttm)	158.32M
Net Income (ttm)	-68.92M
EPS (ttm)	N/A
PE Ratio	52.09
Forward PE	27.80
Profit Margin	-43.53%
Debt to Equity Ratio	0.90

Volume	926,700
Avg Vol	1,812,708
Day's Range	N/A - N/A
Shares Out	89.51M
Stochastic %K	5%
Beta	0.58
Analysts	Strong Sell
Price Target	$106.71